SBIR-STTR Award

Improved Formulations for Anti-Tuberculosis Drugs
Award last edited on: 7/16/14

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$224,284
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Enxian Lu

Company Information

Aucta Pharma (AKA: Aucta Pharmaceuticals LLC~Aucta )

675 US Highway One
North Brunswick, NJ 08902
   (732) 640-0030
   admin@auctapharma.com
   www.auctapharma.com
Location: Multiple
Congr. District: 12
County: Middlesx

Phase I

Contract Number: 272201300025C-0-0-1
Start Date: 9/30/13    Completed: 9/29/14
Phase I year
2013
Phase I Amount
$224,284
To support the development of pediatric oral formulations for the anti-TB drugs isoniazid and streptomycin through various chemical processes.

Project Terms:
Antitubercular Agents; Chemicals; Childhood; Development; drug development; Drug Formulations; improved; isoniazid; Oral; Process; Streptomycin; tuberculosis drugs

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----